IL-12 immunotherapy of BrafV600E-induced papillary thyroid cancer in a mouse model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-12 immunotherapy of BrafV600E-induced papillary thyroid cancer in a mouse model

Published:2015-10-26 Issue:1 Volume:96 Page:89-97
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Parhar Ranjit S,Zou Minjing,Al-Mohanna Futwan A,Baitei Essa Y,Assiri Abdullah M,Meyer Brian F,Shi Yufei

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest2015126.pdf

Reference51 articles.

1. Davies L, Welch HG . Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295:2164–2167.

2. Hundahl SA, Fleming ID, Fremgen AM et al. A National Cancer Data Base Report on 53,856 Cases of Thyroid Carcinoma Treated in the U.S., 1985–1995 [see comments]. Cancer 1998;83:2638–2648.

3. Durante C, Haddy N, Baudin E et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892–2899.

4. Mazzaferri EL, Kloos RT . Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447–1463.

5. Hollenbeak CS, Boltz MM, Schaefer EW et al. Recurrence of differentiated thyroid cancer in the elderly. Eur J Endocrinol 2013;168:549–556.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials;Cancer Research Communications;2024-01-10

2. New Insights into Immune Cells and Immunotherapy for Thyroid Cancer;Immunological Investigations;2023-10-17

3. β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells;Frontiers in Immunology;2023-07-06

4. A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs;BMC Medical Genomics;2022-08-22

5. Analysis of potential biomarkers of response to IL-12 therapy;Journal of Leukocyte Biology;2022-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3